id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S5925 R15075 |
Artama (Carbamazepine) (Controls exposed to Lamotrigine, sick), 2013 | Infant death (0–364 days of age) | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
0.96 [0.12;8.05] C excluded (control group) |
6/1,077 1/173 | 7 | 1,077 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5909 R14890 |
Artama (Carbamazepine) (Controls unexposed, disease free), 2013 | Infant death (0–364 days of age) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.94 [0.86;4.39] excluded (control group) |
6/1,077 2,048/719,509 | 2,054 | 1,077 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5917 R14986 |
Artama (Carbamazepine) (Controls unexposed, sick), 2013 | Infant death (0–364 days of age) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 2.70 [0.72;10.07] | 6/1,077 5/1,793 | 11 | 1,077 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6823 R19281 |
Van der Pol (Carbamazepine) (Controls unexposed, disease free), 1991 | Death (from 6 to 13 years) | throughout pregnancy | prospective cohort | unexposed, disease free excluded | Adjustment: No Matched |
5.26 [0.10;278.85] C excluded (control group) |
0/12 0/61 | 0 | 12 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6825 R19331 |
Van der Pol (Carbamazepine) (Controls unexposed, sick), 1991 | Death (from 6 to 13 years) | throughout pregnancy | prospective cohort | unexposed, sick | Adjustment: No | 0.65 [0.02;17.31] C | 0/12 1/24 | 1 | 12 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 2 studies | 2.22 [0.65;7.53] | 12 | 1,089 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Carbamazepine) (Controls unexposed, sick; 2: Carbamazepine) (Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 6823, 5925, 5909